Show simple item record

Authordc.contributor.authorMerino Osorio, Paulina 
Authordc.contributor.authorMartínez, Daniela 
Authordc.contributor.authorIñíguez Vila, Germán 
Authordc.contributor.authorLópez, Patricia 
Authordc.contributor.authorCassorla Goluboff, Fernando 
Authordc.contributor.authorPérez Bravo, Francisco 
Authordc.contributor.authorCodner Dujovne, Ethel 
Admission datedc.date.accessioned2015-10-15T20:00:05Z
Available datedc.date.available2015-10-15T20:00:05Z
Publication datedc.date.issued2015
Cita de ítemdc.identifier.citationGynecological Endocrinology Volumen: 31 Número: 4 Apr 2015en_US
Identifierdc.identifier.otherDOI: 10.3109/09513590.2014.982086
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/134411
General notedc.descriptionArtículo de publicación ISIen_US
General notedc.descriptionSin acceso a texto completo
Abstractdc.description.abstractIntroduction: Variations in inflammatory markers have been reported in adult women during the luteal phase, but whether these findings are observed during adolescence is unknown. We postulate that higher ultrasensitive C-reactive protein (usCRP) and lower 2-hydroxyestrone (2OHE) levels, an estrogen metabolite with cardioprotective actions, are present during the luteal phase in young women. Aim: To evaluate usCRP levels during the menstrual cycle and to determine its association with 2OHE and 16 alpha-hydroxyestrone (16OHE) in adolescents. Methods: Healthy postmenarcheal adolescents (N= 37) were studied during one menstrual cycle in follicular phase (FP) and luteal phase-like period (LP-L). Results: Elevations in usCRP levels in the LP-L were observed in the entire group and in anovulatory cycles (1.9 +/- 1.1 mg/L in FP to 2.5 +/- 1.8 mg/L in LP-L; p<0.0001). Increases in estrone, estradiol, free and bioavailable estradiol, testosterone, usCRP and 2OHE levels were observed in LP-L compared with FP (p<0.01), with a borderline elevation in IFG-I levels (p=0.06). Conclusions: We report an elevation of usCRP and 2OHE levels during the luteal phase in healthy adolescents. Elevations of this inflammatory marker in anovulatory adolescents without an increase in 2OHE may play a role in metabolic risks associated with chronic anovulation.en_US
Patrocinadordc.description.sponsorshipFondo Nacional de Ciencia y Tecnologia (Fondecyt Grant) by the Chilean Government 1100123en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherInforma Healthcareen_US
Type of licensedc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Keywordsdc.subjectAdolescenciaen_US
Keywordsdc.subjectRiesgo cardiovascularen_US
Keywordsdc.subjectProteína C-Reactivaen_US
Keywordsdc.subjectEstrógenosen_US
Keywordsdc.subjecten_US
Keywordsdc.subjecten_US
Keywordsdc.subjecten_US
Títulodc.titleElevation of C-reactive protein during the luteal phase in healthy adolescentsen_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 Chile
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Chile